TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

A comprehensive report reveals over 25 companies are actively developing new therapies for chronic heart failure, with promising pipeline drugs in various clinical trial stages targeting improved treatment options for an aging population.

Insights
LNVGY   positive

Endorsing the new cloud region as aligned with their managed workplace outcomes strategy


CYTK   positive

Active participant in developing innovative chronic heart failure treatments